• About Us
    • Our vision
    • Our Strategy
    • What we do
    • Our Impact
    • Our team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Support Calendar – What’s On
    • Support for you and your family
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
      • Open Space
      • Group Counselling Programme
    • Recently diagnosed
    • Connect with others
    • Support for 8-14 yrs ‘Turning Point’
    • Support for 14-25 yrs ‘Yes I Can’
    • Schools
    • Siblings
    • End of Life and Bereavement
  • AD Annual International Conference
    • Action Duchenne Annual International Conference 2025
    • Highlights from the Annual Action Duchenne Annual International 2024
    • Annual International Conference 2023 Video Recordings
    • Annual International Conference 2022 Recordings
      • Adults with Duchenne
      • Growing up with Duchenne
      • The Duchenne Journey
      • What is new in Duchenne research?
  • News, Webinars and Blogs
    • News
    • Webinar Series 2025
      • Webinar Series 2025
      • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Blogs
  • Support Us
    • Friends of Action Duchenne
    • Fundraising Events and Challenges
    • Take on a challenge for Duchenne
  •  0 items - Free
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • SHOP
  • My account
  •  0 items - Free

Action Duchenne

Header Right

  • About Us
    • Our vision
    • Our Strategy
    • What we do
    • Our Impact
    • Our team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Support Calendar – What’s On
    • Support for you and your family
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
      • Open Space
      • Group Counselling Programme
    • Recently diagnosed
    • Connect with others
    • Support for 8-14 yrs ‘Turning Point’
    • Support for 14-25 yrs ‘Yes I Can’
    • Schools
    • Siblings
    • End of Life and Bereavement
  • AD Annual International Conference
    • Action Duchenne Annual International Conference 2025
    • Highlights from the Annual Action Duchenne Annual International 2024
    • Annual International Conference 2023 Video Recordings
    • Annual International Conference 2022 Recordings
      • Adults with Duchenne
      • Growing up with Duchenne
      • The Duchenne Journey
      • What is new in Duchenne research?
  • News, Webinars and Blogs
    • News
    • Webinar Series 2025
      • Webinar Series 2025
      • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Blogs
  • Support Us
    • Friends of Action Duchenne
    • Fundraising Events and Challenges
    • Take on a challenge for Duchenne

News

You are here: Home / News

Sarepta Therapeutics Announces Positive Update on ELEVIDYS (delandistrogene moxeparvovec-rokl) Regulatory Progress for Duchenne Muscular Dystrophy (DMD)

June 21, 2024 by John Marrin

Sarepta Therapeutics, Inc. today provided an update on the regulatory progress of ELEVIDYS (delandistrogene moxeparvovec-rokl), its gene therapy for …

Sarepta Therapeutics Announces Positive Update on ELEVIDYS (delandistrogene moxeparvovec-rokl) Regulatory Progress for Duchenne Muscular Dystrophy (DMD)Read More

Start your Summer as an AD Champion at the Parellel Windsor Festival of Inclusivity

June 9, 2024 by Lizzie Cox

Start your Summer as an Action Duchenne Champion Action Duchenne are proud to be a Parallel charity partner for their flagship Festival of …

Start your Summer as an AD Champion at the Parellel Windsor Festival of InclusivityRead More

SOT OXFORD

June 4, 2024 by Lizzie Cox

SOT OXFORD Book your FREE place on our Oxford Science workshop on 11th June, running from 10.30am- 3:00pm. …

SOT OXFORDRead More

Come together with the Duchenne community at Action Duchenne’s Annual International Conference 2024

June 1, 2024 by Lizzie Cox

Come together with the Duchenne community at Action Duchenne's Annual International Conference 2024 Friday 8th & Saturday 9th November 2024, …

Come together with the Duchenne community at Action Duchenne’s Annual International Conference 2024Read More

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD

May 29, 2024 by John Marrin

Dyne Therapeutics announced on the 20th of May, positive clinical data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic …

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMDRead More

Calling everyone from Scotland and Wales – Tell us what YOU think!

May 27, 2024 by Lizzie Cox

Tell us what YOU think We are contacting all of our families, clinicians, schools and care professionals across Scotland and Wales as we try to …

Calling everyone from Scotland and Wales – Tell us what YOU think!Read More

MHRA Translarna Survey

May 22, 2024 by Lizzie Cox

Introduction In 2014, the European Medicines Agency (EMA), granted a ‘Conditional Marketing Authorisation’ to Translarna for the treatment of …

MHRA Translarna SurveyRead More

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation

May 20, 2024 by Lizzie Cox

PTC Therapeutics has announced today that the European Commission (EC) has decided not to adopt the European Medicine Agency (EMA) Committee for …

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluationRead More

Spring Webinar : BIND Study

May 16, 2024 by Lizzie Cox

The BIND project: Learning and behaviour challenges in Duchenne and Becker Muscular Dystrophies Join us on Wednesday 29th May at 5:30 pm for the …

Spring Webinar : BIND StudyRead More

Links and Resources

May 13, 2024 by Lizzie Cox

Here are some links to other charities and organisations who have been part of Yes I Can sessions, or that you might find useful. Pathfinders …

Links and ResourcesRead More

Science on Tour 2024 – Register your Interest

May 7, 2024 by Lizzie Cox

Behind the scenes at Action Duchenne, our Science Communication team have been working hard to put together 2024 Science on Tour Programme. The …

Science on Tour 2024 – Register your InterestRead More

Spring Webinar – Dr Vasantha Gowda ‘DMD and Emergencies’

April 26, 2024 by Lizzie Cox

Join us on Saturday 11th May at 5pm for the next in our series of webinars. Dr Vasantha Gowda, consultant in paediatric neurology and neuromuscular …

Spring Webinar – Dr Vasantha Gowda ‘DMD and Emergencies’Read More

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Interim pages omitted …
  • Page 47
  • Go to Next Page »

Footer

Action Duchenne
5th Floor, Mariner House
62 Prince Street
Bristol
BS1 4QD

07535 498 506
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852

Like most websites we use cookies to deliver a personalised service. To use the website as intended please accept cookies.
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT